GOLDMAN SACHS GROUP INC - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 60 filers reported holding SCPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$148,765
-85.0%
20,894
-80.9%
0.00%
Q1 2023$989,827
+423.8%
109,132
+314.1%
0.00%
Q4 2022$188,965
-73.2%
26,355
-77.1%
0.00%
Q2 2021$704,000
-83.7%
115,264
-82.2%
0.00%
-100.0%
Q1 2021$4,314,000
+1954.3%
648,770
+1531.4%
0.00%
Q4 2020$210,000
-20.5%
39,768
+12.0%
0.00%
Q3 2020$264,000
+88.6%
35,494
+86.7%
0.00%
Q2 2020$140,000
+10.2%
19,012
+10.9%
0.00%
Q1 2020$127,000
+101.6%
17,148
+59.7%
0.00%
Q3 2018$63,000
-72.4%
10,737
-73.3%
0.00%
Q2 2018$228,000
-40.8%
40,287
+29.6%
0.00%
Q1 2018$385,000
-41.0%
31,086
-42.5%
0.00%
Q4 2017$653,00054,0320.00%
Other shareholders

There were no reported owners of SCPHARMACEUTICALS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of SCPHARMACEUTICALS INC shareholders